Checked
Stroke Clinical Trials in California
Open studies with at least one site in the state
- Open studies
- 78
- With a site in California
- Most studies in
- Los Angeles
- 20 of the studies shown
Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.
Studies
50 of 78, recruiting studies first. Cities are where the study lists a California site.
- Telerehabilitation In The Home After StrokeRecruitingNCT06682429· University of California, Los Angeles
Los Angeles, Downey, Irvine, Pomona and 1 more
- Implementing Transcranial Direct Current Stimulation in a Rehabilitation SettingRecruitingNCT07535788· Casa Colina Hospital and Centers for Healthcare
Pomona
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial FibrillationRecruitingPhase 3NCT07626411· Regeneron Pharmaceuticals
Fremont, Huntington Beach, La Jolla, Newport Beach and 5 more
- Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain OcclusionsRecruitingNCT06029491· RapidPulse, Inc
Torrance
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationRecruitingPhase 2NCT07175428· Regeneron Pharmaceuticals
Covina, Encinitas, Fremont, Huntington Beach and 6 more
- Continuous Dual Aspiration Technique With Zoom System for StrokeRecruitingNCT07491952· Imperative Care, Inc.
Walnut Creek
- Strategy for Improving Stroke Treatment ResponseRecruitingPhase 2NCT05948566· Translational Sciences, Inc.
La Jolla, Los Angeles, Sacramento, San Diego
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationRecruitingPhase 3NCT05836987· Johns Hopkins University
Los Angeles, Sacramento, San Diego, San Francisco and 1 more
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitableRecruitingPhase 3NCT07430956· Regeneron Pharmaceuticals
Fremont, Huntington Beach, La Jolla, Northridge and 4 more
- Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)RecruitingPhase 2NCT06226805· Basking Biosciences, Inc.
Burlingame, Long Beach, San Francisco, Torrance
- The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial AneurysmsRecruitingNCT07143019· phenox Inc.
Los Angeles, San Francisco
- Cognition and Imaging With TigertrieverRecruitingNCT05531461· Rapid Medical
Los Angeles, Orange
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy TrialRecruitingPhase 3NCT05611242· Mercy Health Ohio
Glendale, Irvine, Pomona, Sacramento and 1 more
- CoMind Early Feasibility StudyRecruitingNCT06368648· CoMind Technologies Limited
Sacramento
- kTMP-Enhanced Motor Rehabilitation for Chronic Stroke Recovery (KULMINATE) PilotRecruitingNCT07631078· Magnetic Tides
San Francisco
- Comparing the Safety and Efficacy of Apixaban and RivaroxabanRecruitingPhase 4NCT06953726· VA Office of Research and Development
West Los Angeles
- Optimizing Reperfusion to Improve Outcomes and Neurologic FunctionRecruitingPhase 2, Phase 3NCT06990867· Corxel Pharmaceuticals
Long Beach, Los Angeles, Sacramento
- The Fourth Left Atrial Appendage Occlusion StudyRecruitingNCT05963698· Hamilton Health Sciences Corporation
Fountain Valley, Loma Linda, Los Angeles, Pasadena and 1 more
- Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokeRecruitingPhase 3NCT05691244· Pharmazz, Inc.
Carmichael, Oxnard
- Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverYRecruitingNCT04916210· Massachusetts General Hospital
Los Angeles, San Diego
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)RecruitingPhase 2, Phase 3NCT05065216· DiaMedica Therapeutics Inc
Los Angeles, Torrance, Arcadia, Glendale and 1 more
- Treatment With Endovascular Intervention for STroke Patients With Existing DisabilityRecruitingNCT05911568· University of Cincinnati
Los Angeles, Palo Alto, San Diego
- CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic MaterialRecruitingNCT07276711· EmStop Inc
Thousand Oaks
- Safety and Efficacy of J147 in Acute Ischemic StrokeRecruitingPhase 2NCT07430917· Abrexa Pharmaceuticals, Inc.
Long Beach
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield TrialsRecruitingNCT05338697· Yale University
Los Angeles, San Francisco, Redwood City
- Rapid Evacuation and Access of Cerebral Hemorrhage TrialRecruitingNCT06870812· Emory University
Palo Alto
- A Study of TAK-755 in Adults With Acute Ischemic StrokeRecruitingPhase 2NCT07392450· Takeda
San Francisco
- Clevidipine for the Antihypertensive Treatment of Acute Intracerebral HemorrhageRecruitingNCT06402968· Zeenat Qureshi Stroke Institute
Irvine, Lancaster, Palo Alto
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruitingNCT03821129· W.L.Gore & Associates
La Jolla, Loma Linda, San Francisco, Santa Barbara
- Examining Relationships Between Musculoskeletal Function Measurements of Movement Efficiency and Nervous System Function After Chronic StrokeRecruitingNCT07737873· University of California, Davis
Sacramento
- Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke PatientsRecruitingNCT06999122· EMVision Medical Devices Ltd
Los Angeles
- Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO StudyRecruitingNCT07172464· Recross Cardio, Inc.
Los Angeles
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGRecruitingPhase 3NCT04045665· Icahn School of Medicine at Mount Sinai
Los Angeles, Stanford
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsRecruitingPhase 1, Phase 2NCT02638701· University of California, San Francisco
San Francisco
- Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial AtherosclerosisRecruitingNCT05518305· University of California, Los Angeles
Los Angeles
- Feasibility of the BrainGate2 Neural Interface System in Persons With TetraplegiaRecruitingNCT05724173· Leigh R. Hochberg, MD, PhD.
Stanford
- Recovery Trajectory for Coma and Disorders of ConsciousnessRecruitingNCT07614074· University of California, San Francisco
San Francisco
- BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With TetraplegiaRecruitingNCT00912041· Leigh R. Hochberg, MD, PhD.
Sacramento, Stanford
- Ultrasound Stimulation for Patients in a Disorder of ConsciousnessRecruitingNCT06939348· University of California, Los Angeles
Los Angeles, Pomona
- ECoG BMI for Motor and Speech ControlRecruitingNCT03698149· Karunesh Ganguly
San Francisco
- Transcranial Direct Current Stimulation for Treatment of Acute Ischemic StrokeRecruitingPhase 2NCT06440707· University of California, Los Angeles
Los Angeles
- Driver Simulator Training to Improve Driving After StrokeRecruitingNCT06672107· VA Office of Research and Development
Sacramento
- Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)RecruitingNCT07357428· Paradromics
Sacramento
- EEG Changes and DNA Markers Related to taVNS in Stroke Patients: a Preliminary StudyRecruitingNCT06226493· Casa Colina Hospital and Centers for Healthcare
Pomona
- CANF-Comb-II PET-MR in Atherosclerosis MultisiteRecruitingNCT05838547· Washington University School of Medicine
Los Angeles
- Aphasia Physical EXercise Study: Randomized TrialRecruitingNCT07281313· University of California, Berkeley
San Francisco, Berkeley, Hayward
- Non-Invasive Detection of Right-to-Left Cardiac ShuntsRecruitingNCT07420400· Scripps Health
La Jolla
- North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)RecruitingNCT01694940· Columbia University
San Diego, Stanford
- Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) StudyRecruitingNCT05677880· University of Wisconsin, Madison
Los Angeles, San Francisco
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With StressRecruitingPhase 4NCT03968393· Population Health Research Institute
Los Angeles
Other heart, blood and metabolism studies in California
Frequently asked questions
- Are there stroke clinical trials in California?
- Yes. 78 stroke studies on ClinicalTrials.gov list at least one site in California and are recruiting, about to recruit or enrolling by invitation, including sites in Los Angeles, San Francisco, Sacramento.
- What does recruiting mean?
- Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
- How do I join a clinical trial?
- Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.
Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/29/2026
Share: